Standard management of anemia in pregnancy.

doi:10.7504/fk2014050111

Abstract

Abstract:

Abstract：Anemia, a common complication during pregnancy affecting the health of mothers worldwide, two thirds of them being from Asia, has been an important problem of prenatal preventive health care. Blood volume expansion with a disproportionate plasma volume increase is an important reason for high incidence of anemia in pregnancy. Nutritional anemia, particularly iron deficiency anemia is common. The main managements of iron deficiency anemia are oral iron supplements and parenteral iron therapy. In addition, thalassemia, caused by genetic defect, threaten the health of mothers and fetuses. Therefore,prevention,detection and treatment at early stage are of great importance for the mothers and fetuses． 

Key words: pregnancy；anemia, iron deficiency anemia；thalassemia

摘要：

贫血是妊娠期常见的内科合并症，影响着全球5600万的妊娠期妇女的健康，其中2/3来自亚洲，是围生期预防保健的重要内容。妊娠期血容量的增加与血浆及红细胞的增加不成比例是贫血多发的重要原因。其中，营养性贫血尤其是缺铁性贫血最为常见，目前最主要的防治方法是口服铁剂和注射铁剂补铁。同时，由于遗传缺陷引起的地中海贫血严重威胁着母儿的健康，故其预防、早期识别和相应的治疗措施对母儿的安全具有重要意义。

关键词: 妊娠期, 贫血, 缺铁性贫血, 地中海贫血

CLC Number:

R714.254

TANG Yu-ping,YING Hao.. Standard management of anemia in pregnancy.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2014050111.

唐宇平，应豪. 妊娠期贫血及其规范管理[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2014050111.

References



[1］ World Health Organization. In de Benoist B, Mclean E,et al. Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. Geneva: World Health Organization, 2008 (NLM: WH 155).

[2］靳蕾,叶荣伟,王荣琴,等.妇女孕前贫血与孕期贫血间关系的研究[J].中华流行病学杂志，2010，31（1）：114.

[3］中国儿童、孕妇、育龄妇女铁缺乏症流行病学调查协作组．中国孕妇、育龄妇女铁缺乏症患病率调查[J]．中华血液学杂志，2004，25：653-657．

[4］ Reveiz L, Gyte GM, Cuervo LG, et al. Treatments for iron-deficiency anaemia in pregnancy[J]. Cochrane Database Syst Rev,2012，1:CD003094.

[5］ Breymann C,Bian XM,Blanco-Capito LR,et al.Expert recommendations for the diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region[J].J Perinat Med,2011,39(2):113-121.

[6］ Auerbach M,Ballard H.Clinical use of intravenous iron: administration, efficacy, and safety [J].Hematology Am Soc Hematol Educ Program,2010:338-347.

[7］中华医学会妇产科学分会，漆洪波，常青，等.孕前和孕期保健指南[J].中华妇产科杂志，2011，46(2):150-153.

[8］ World Health Organization. In Vir SC & Cavalli-Sforza T (eds.). Weekly iron folic acid supplementation (WIFS) program for women of reproductive age (WRA): an analysis of best program practices. Geneva: World Health Organization, 2011.

[9］ World Health Organization. Iron deficiency anaemia assessment prevention and control: a guide for programme managers. Geneva: World Health Organization, 2001. 132 (WHO/ NHD/01.3).

[10］ Pena- Rosas JP & Viteri FE. Effects and safety of preventive oral iron or iron + folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev 2009. Issue 4. Art.No: CD004736. DOI: 10.1002/ 14651858. CD004736 pub 3.

[11］ Molloy AM, Kirke PN, Troendle JF，et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification[J]. Pediatrics ，2009，123(3): 917-923.

[1]	CUI Yu-tong，LI Xiao-tian. Anemia during pregnancy and adverse pregnantcy outcomes. [J]. Acta Metallurgica Sinica, 2020, 36(5): 408-412.
[2]	LIANG Mei-ying，XU Xue. Pre-pregnancy assessment and management of pregnancy complicated with hematology system diseases. [J]. Acta Metallurgica Sinica, 2017, 33(3): 259-263.